VideoMatt Herper’s tour de force article in the latest Forbes magazine suggests that companies and researchers are – perhaps – turning the tables on cancer using novel immunotherapies that are producing nearly unheard of outcomes even in late stage disease. The trillion dollar question: Can we afford to win the […]
Sure, We'll (Eventually) Beat Cancer. But Can We Afford To?
댓글 없음:
댓글 쓰기